Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing rivastigmine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rivastigmine (as rivastigmine tartrate) 1.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rivastigmine (as rivastigmine tartrate) 3 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rivastigmine (as rivastigmine tartrate) 6 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rivastigmine 2mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rivastigmine (as rivastigmine tartrate) 2 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rivastigmine tartrate |
Is a |
False |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rivastigmine 4.6mg/24 hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rivastigmine 9.5mg/24 hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing rivastigmine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing rivastigmine in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rivastigmine (as rivastigmine tartrate) 1.5 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rivastigmine (as rivastigmine tartrate) 3 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rivastigmine (as rivastigmine tartrate) 4.5 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rivastigmine (as rivastigmine tartrate) 6 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rivastigmine tartrate |
Is modification of (attribute) |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing rivastigmine in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rivastigmine (as rivastigmine tartrate) 2 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rivastigmine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rivastigmine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rivastigmine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rivastigmine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rivastigmine only product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rivastigmine 192 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rivastigmine 192 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely rivastigmine 396 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has precise active ingredient |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely rivastigmine 396 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has basis of strength substance (attribute) |
True |
Rivastigmine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |